
Michelle Gaylord
Associate Director @ Pfizer
About
Scientific expertise in serological diagnostics, automation, immunoassay development, mucosal immunology, inflammatory bowel disease, infectious disease and host-pathogen interactions
United States
Pearl River
Pharmaceuticals
Cell Culture, Clinical Research, Immunology, Microbiology, Molecular Cloning, Fluorescence Microscopy, Flow Cytometry, Mucosal Immunology, Infectious Diseases, Innate Immunity, Lyme disease, Inflammatory Bowel Disease, T cells, Molecular Biology
Experience

Postdoctoral Fellow, Department of Medicine, Division of Gastroenterology
The Icahn School of Medicine at Mount Sinai
Greater New York City Area
Research topics include: Mucosal Immunology Inflammatory Bowel Disease Gut Microbiome Intestinal Transplantation

Graduate Student, Ph.D. Candidate
Projects: Explored the initial host-pathogen interactions that occur between human immune cells and B. burgdorferi, the Lyme disease spirochete Investigated the mechanism(s) that enable the bacterium to subvert innate immune responses and cause disease

Summer Intern, part-time employee
Wyeth Pharmaceuticals (now Pfizer)
Pearl River, New York
Interned as a Document Coordinator in the Quality Assurance Documentation Group in the Vaccines and Biotech branch of Wyeth.
Michelle Gaylord's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.






